Transactional

Life Sciences

Extensive representation of multinational pharmaceutical companies, world-class universities, and dynamic, emerging growth companies has given the multidisciplinary Wiggin and Dana Life Sciences Practice Group robust capabilities and a deep understanding of the unique business objectives and concerns of our clients in the biotechnology, pharmaceutical, and medical device industries. That breadth and depth of experience means greater flexibility, responsiveness, and ability to anticipate your needs.

For more than 30 years, Wiggin and Dana has served a diverse group of life sciences clients, including the world's largest health care companies, midsize public and private biotechnology companies, university spinoffs, individual scientists, and entrepreneurs—in their most vital matters, including

  • Mergers and acquisitions
  • Strategic partnerships
  • Other collaborative research, development, and licensing arrangements
  • Distribution, co-promotion, and marketing agreements
  • Investigator-sponsored and industry-sponsored research arrangements
  • Manufacturing and distribution agreements
  • Clinical trial operations and execution
  • Intellectual property matters
  • Academic technology transfer
  • Privacy and data protection
  • Other health and medical industry matters
  • Corporate finance (public and private)
  • PIPE (Private Investment in Public Equity) financings
  • Litigation and dispute resolution
  • Export control and sanctions
  • Real estate, construction, and facilities matters
  • Special issues facing scientists and universities
  • Human resource issues

Our clients come from across the United States and around the world. Our attorneys have practical experience in the life sciences industries, hold advanced degrees in scientific and technical fields, regularly author articles in industry-related publications, and frequently present before industry-related groups.